Justyna Zofia Kostro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Justyna Zofia Kostro has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Andrzej Hellmann
Department of Surgical Oncology, Transplant Surgery and General Surgery, Medical University of Gdańsk, 80-214 Gdansk, Poland
3 shared publications - Alicja Dębska-Ślizień
Department of Nephrology, Transplantology and Internal Medicine, Faculty of Medicine, Medical University of Gdansk, 80-210 Gdansk, Poland
2 shared publications Stanisław Hać
Department of General, Endocrine and Transplant Surgery, Medical University of Gdansk, Gdansk, Poland
2 shared publicationsZ. Śledziński
Department of General, Endocrine, and Transplant Surgery, Medical University of Gdańsk, Poland
2 shared publicationsA. Dębska-Ślizień
Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland
1 shared publicationAlicja Dębska-Ślizień
Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland
1 shared publication
Latest Publications
- Open Access
- 15 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (33) , e43981
Post-transplant diabetes mellitus in kidney transplant recipients: A prospective cohort study of risk factors and clinical outcomes
Post-transplant diabetes mellitus (PTDM) is a common metabolic complication following kidney transplantation and is associated with an increased risk of graft failure, cardiovascular disease, infections, and mortality. We prospectively analyzed the risk factors and clinical consequences of PTDM in patients who underwent kidney transplantation at our center. The study included 130 transplant recipients without preexisting diabetes (79 males, 51 females; mean age: 47.6 years). PTDM was defined as the requirement for pharmacologic treatment at least 3 months after transplantation or based on the oral glucose tolerance test. The observation period ranged from 4 to 75 months. The incidence of PTDM was 21.5% (28/130). Patients who developed PTDM were older ( P = .02) and had a higher body mass index ( P = .04). Median fasting glucose and HbA1c levels prior to transplantation were significantly higher in patients who later developed PTDM. No significant differences were observed in sex, Charlson Comorbidity Index, dialysis method or duration, number of HLA mismatches, frequency of acute rejection, delayed graft function, reoperation, graft function, steroid dose, or baseline serum levels of insulin, C-peptide, lipid profile, or markers of insulin resistance. Tacrolimus was part of the immunosuppressive regimen in 89% of PTDM patients and 78% of non-PTDM patients ( P > .05). In this cohort, general risk factors for diabetes appeared to play a greater role in the development of PTDM than transplantation-specific variables. Simple pre-transplant indicators such as blood glucose and HbA1c may help identify patients at increased risk of PTDM.
- 15 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (33) , e43981
Open AccessPost-transplant diabetes mellitus in kidney transplant recipients: A prospective cohort study of risk factors and clinical outcomes
Post-transplant diabetes mellitus (PTDM) is a common metabolic complication following kidney transplantation and is associated with an increased risk of graft failure, cardiovascular disease, infections, and mortality. We prospectively analyzed the risk factors and clinical consequences of PTDM in patients who underwent kidney transplantation at our center. The study included 130 transplant recipients without preexisting diabetes (79 males, 51 females; mean age: 47.6 years). PTDM was defined as the requirement for pharmacologic treatment at least 3 months after transplantation or based on the oral glucose tolerance test. The observation period ranged from 4 to 75 months. The incidence of PTDM was 21.5% (28/130). Patients who developed PTDM were older ( P = .02) and had a higher body mass index ( P = .04). Median fasting glucose and HbA1c levels prior to transplantation were significantly higher in patients who later developed PTDM. No significant differences were observed in sex, Charlson Comorbidity Index, dialysis method or duration, number of HLA mismatches, frequency of acute rejection, delayed graft function, reoperation, graft function, steroid dose, or baseline serum levels of insulin, C-peptide, lipid profile, or markers of insulin resistance. Tacrolimus was part of the immunosuppressive regimen in 89% of PTDM patients and 78% of non-PTDM patients ( P > .05). In this cohort, general risk factors for diabetes appeared to play a greater role in the development of PTDM than transplantation-specific variables. Simple pre-transplant indicators such as blood glucose and HbA1c may help identify patients at increased risk of PTDM.
- Open Access
- 4 June 2022
- Published by Elsevier in Transplantation Proceedings
- Vol. 54 (4) , 955-959
Kidney Transplantation in Patients After Bariatric Surgery: High-Volume Bariatric and Transplant Center Experience
- 4 June 2022
- Published by Elsevier in Transplantation Proceedings
- Vol. 54 (4) , 955-959
Open AccessKidney Transplantation in Patients After Bariatric Surgery: High-Volume Bariatric and Transplant Center Experience
- Open Access
- 1 January 2018
- Published by Termedia Sp. z.o.o. in Gastroenterology Review
- Vol. 13 (3) , 251-257
Cholecystectomy after endoscopic retrograde cholangiopancreatography – effect of time on treatment outcomes
- 1 January 2018
- Published by Termedia Sp. z.o.o. in Gastroenterology Review
- Vol. 13 (3) , 251-257
Open AccessCholecystectomy after endoscopic retrograde cholangiopancreatography – effect of time on treatment outcomes
- 1 January 2016
- Published by Elsevier in Transplantation Proceedings
- Vol. 48 (1) , 50-54
Quality of Life After Kidney Transplantation: A Prospective Study
- 1 January 2016
- Published by Elsevier in Transplantation Proceedings
- Vol. 48 (1) , 50-54
Quality of Life After Kidney Transplantation: A Prospective Study
- 1 March 2015
- Published by Elsevier in Transplantation Proceedings
- Vol. 47 (2) , 384-387
The Use of Tenckhoff Catheters for Draining of Symptomatic Lymphoceles: A Review of Literature and Our Experience
- 1 March 2015
- Published by Elsevier in Transplantation Proceedings
- Vol. 47 (2) , 384-387
The Use of Tenckhoff Catheters for Draining of Symptomatic Lymphoceles: A Review of Literature and Our Experience